Park Dae Yong, Hanna Jonathan M, Kadian Sumeet, Kadian Mannat, Jones W Schuyler, Damluji Abdulla Al, Kochar Ajar, Curtis Jeptha P, Nanna Michael G
Department of Medicine, Cook County Health, Chicago, IL, USA.
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
J Geriatr Cardiol. 2022 Sep 28;19(9):631-642. doi: 10.11909/j.issn.1671-5411.2022.09.006.
Percutaneous coronary intervention (PCI) for stable ischemic heart disease (SIHD) in older adults requires a meticulous assessment of procedural risks and benefits, but contemporary data on outcomes in this population is lacking. Therefore, we examined the risk of near-term readmission, bleeding, and mortality in high-risk cohort of older adults undergoing inpatient PCI for SIHD.
We analyzed the National Readmissions Database from 2017 to 2018 to identify index hospitalizations in which PCI was performed for SIHD. Patients were stratified into those ≥ 75 years old (older adults) and those < 75 years old. The primary outcome was 90-day readmission. Secondary outcomes included in-hospital mortality, hospital length of stay (LOS), and total hospital charge.
A total of 74,516 patients underwent inpatient PCI for SIHD, of whom 24,075 were older adults. Older adult patients had higher odds of in-hospital mortality (OR = 2.00, 95% CI: 1.68-2.38), intracranial hemorrhage (OR = 2.03, 95% CI: 1.24-3.34), and gastrointestinal hemorrhage (OR = 1.72, 95% CI: 1.43-2.07) during index hospitalization, with longer LOS and in-hospital charge. Older adults also experienced a higher hazard of 90-day readmission for any cause (HR = 1.61, 95% CI: 1.57-1.66) and cardiovascular causes (HR = 1.84, 95% CI: 1.77-1.91).
Older adults undergoing inpatient PCI for SIHD were at increased risk for in-hospital mortality, periprocedural morbidities, higher cost, and readmissions compared with younger adults. Understanding these differences may improve shared decision-making for patients with SIHD being considered for PCI.
对老年稳定型缺血性心脏病(SIHD)患者进行经皮冠状动脉介入治疗(PCI)需要对手术风险和益处进行细致评估,但目前缺乏该人群治疗结果的相关数据。因此,我们研究了因SIHD接受住院PCI治疗的高危老年人群近期再入院、出血和死亡的风险。
我们分析了2017年至2018年的国家再入院数据库,以确定因SIHD进行PCI治疗的索引住院病例。患者被分为年龄≥75岁(老年人)和年龄<75岁两组。主要结局是90天再入院。次要结局包括住院死亡率、住院时间(LOS)和总住院费用。
共有74516例患者因SIHD接受住院PCI治疗,其中24075例为老年人。老年患者在索引住院期间发生院内死亡(OR = 2.00,95%CI:1.68 - 2.38)、颅内出血(OR = 2.03,95%CI:1.24 - 3.34)和胃肠道出血(OR = 1.72,95%CI:1.43 - 2.07)的几率更高,住院时间更长,住院费用更高。老年人因任何原因(HR = 1.61,95%CI:1.57 - 1.66)和心血管原因(HR = 1.84,95%CI:1.77 - 1.91)发生90天再入院的风险也更高。
与年轻患者相比,因SIHD接受住院PCI治疗的老年人发生院内死亡、围手术期并发症、费用更高和再入院的风险增加。了解这些差异可能会改善考虑接受PCI治疗的SIHD患者的共同决策。